CD4 and myeloid sarcoma: This phenomenon was observed after STAT1 expression in a human squamous carcinoma cell line and type I interferon treatment of murine L-929 cells, human Daudi lymphoblastoid cells and isolated CD4+ lymphocytes from MS patients [30,31,32].